COMMUNIQUÉS West-GlobeNewswire

Next Green Wave Successfully Completes First Premium Cannabis Harvest
22/08/2019
And Provides Executive Management Update VANCOUVER, British Columbia, Aug. 22, 2019 (GLOBE NEWSWIRE) -- Next Green Wave Holdings Inc. (CSE: NGW) (OTCQX: NXGWF) ("Next Green Wave", “NGW” or the "Company") announces that [...]
AlloSure for Heart Transplant Patients Receives CMS Draft Coverage
22/08/2019
CareDx expands leadership with cfDNA for transplant care BRISBANE, Calif., Aug. 22, 2019 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development and [...]
Coherus BioSciences Announces New Employment Inducement Grants
22/08/2019
REDWOOD CITY, Calif., Aug. 22, 2019 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq: CHRS), today announced that effective August 21, 2019, the compensation committee of the company’s board of directors granted 13 [...]
Rafarma’s Agri-Tech Keeping Cannabis Production “High”
22/08/2019
Ljubljana, Slovenia, Aug. 22, 2019 (GLOBE NEWSWIRE) -- RAFARMA PHARMACEUTICALS INC. “OTC:(RAFA) - Rafarma is continuing to actively promote its hemp oil products in the European market. Despite the adverse weather [...]
Pressure BioSciences Announces Two More Purchase Orders for its Revolutionary BaroShear K45 Processing System for Manufacturing Water-Soluble CBD
22/08/2019
Company Forecasts All 12 Systems in Current Build Cycle Will Be Sold by September 30, 2019 and Reiterates Previous Guidance for More Than Doubling of Annual Revenue in 2020 SOUTH EASTON, MA, Aug. 22, 2019 (GLOBE [...]
Seelos Therapeutics Announces FDA Acceptance of IND Application for SLS-005 for Mucopolysaccharidosis Type III (Sanfilippo Syndrome)
22/08/2019
Seelos to Proceed with Trial Enrollment and Dosing for Phase IIb/III Trial for Sanfilippo Syndrome Type A and B Patients NEW YORK, Aug. 22, 2019 (GLOBE NEWSWIRE) -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical- [...]
Protalix BioTherapeutics Focuses on Evaluating and Pursuing Alternatives to Maximize Shareholder Value through Refinancing & Strategic Partnerships
22/08/2019
CARMIEL, Israel, Aug. 22, 2019 (GLOBE NEWSWIRE) -- Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic [...]
CV Sciences, Inc. Announces Distribution Partnership With The Vitamin Shoppe
22/08/2019
Partnership Broadens Distribution of PlusCBD™ Oil Products to More Than 380 Vitamin Shoppe Locations SAN DIEGO, Aug. 22, 2019 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us [...]
Aurora Spine Corporation Reports Record Q2 Revenue; Files Condensed Interim Consolidated Financial Statements for the Three and Six Months Ended June 30, 2019
22/08/2019
NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES CARLSBAD, Calif., Aug. 22, 2019 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) announces [...]
Genprex (GNPX) Featured in NetworkNewsWire Publication Discussing Company’s Milestone Achievements
22/08/2019
NEW YORK, Aug. 22, 2019 (GLOBE NEWSWIRE) -- via NetworkWire -- Genprex Inc. (NASDAQ:GNPX) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), a multifaceted financial news and publishing [...]
Golden Leaf Holdings Announces Overwhelming Approval of Extraordinary Resolutions By Debenture Holders
22/08/2019
TORONTO, Aug. 22, 2019 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“Golden Leaf” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a pioneer cannabis oil solutions company and dispensary operator built around recognized [...]
Immutep Granted European Patent for Eftilagimod Alpha in Cancer
22/08/2019
SYDNEY, Australia, Aug. 22, 2019 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep“ or “the Company”), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune [...]
Maverick Technology Solutions Announces the Launch of the Groundbreaking ROSINBOMB™ M-60 Extraction Press With Patent Pending Flow Channel Technology™
22/08/2019
Solventless, High-Quality, Large Volume Extract Production Now a Reality RENO, Nev., Aug. 22, 2019 (GLOBE NEWSWIRE) -- Maverick Technology Solutions (OTC:MVRK), industry leading developer and manufacturer of the highly [...]
Bainbridge Health Partners with Tabula Rasa HealthCare’s subsidiary DoseMe To Expand Medication Management Capabilities to Health System(s)
22/08/2019
MOORESTOWN, N.J., Aug. 22, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, today announced a partnership between its [...]
Mustang Bio and St. Jude Children’s Research Hospital announce MB-107 lentiviral gene therapy for X-linked Severe Combined Immunodeficiency (XSCID) granted regenerative medicine advanced therapy (RMAT) designation from FDA
22/08/2019
RMAT designation follows positive Phase 1/2 clinical data published in the New England Journal of Medicine Designation to facilitate expedited development and review of MB-107 for XSCID NEW YORK and MEMPHIS, Tenn., Aug [...]
Inovalon to Present at the Citi 2019 Global Technology Conference
22/08/2019
BOWIE, Md., Aug. 22, 2019 (GLOBE NEWSWIRE) -- Inovalon (Nasdaq: INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, today announced that Keith Dunleavy, M.D., chief executive officer [...]
ADMA Biologics Announces Commercial Relaunch and its First Commercial Sales of BIVIGAM®
22/08/2019
RAMSEY, N.J. and BOCA RATON, Fla., Aug. 22, 2019 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA” or the “Company”), a vertically integrated commercial biopharmaceutical and specialty immunoglobulin [...]
Myriad Applauds the U.S. Preventive Services Task Force Recommendation on BRCA-Related Cancer Prevention
22/08/2019
More Women May Benefit from Hereditary Cancer Risk Assessment and Genetic Testing SALT LAKE CITY, Aug. 22, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in molecular diagnostics and [...]
Clearside Biomedical Provides New Drug Application Update for XIPEREᵀᴹ (triamcinolone acetonide suprachoroidal injectable suspension)
22/08/2019
ALPHARETTA, Ga., Aug. 22, 2019 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with [...]

Pages